rbd003

Robert B. Den, MD

Contact Dr. Den

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6702
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncology
  2. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
  3. Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
  4. Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy
  5. Reply to Nicola Fossati, Giorgio Gandaglia, Alberto Bossi, Francesco Montorsi, Alberto Briganti's Letter to the Editor re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy After Radical Prostatectomy. Eur Urol 2016;70:588–96
  6. Radioisotopes in management of metastatic prostate cancer
  7. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy
  8. Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome
  9. The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer
  10. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study
  11. The landscape of prognostic outlier genes in high-risk prostate cancer
  12. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities
  13. Dosing, administration, and safety of radium-223: How i do it
  14. Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer
  15. Novel targeted siRNA-loaded hybrid nanoparticles: Preparation, characterization and in vitro evaluation
  16. Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data
  17. Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis
  18. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy
  19. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer
  20. Uncertainties encountered in implementation of adaptive planning with in vivo dosimeters